Loading...
Loading...
NEW YORK, NY · CIK 0001263508
New positions
8
Added to
26
Trimmed
6
Exited
9
BAKER BROS. ADVISORS LP (NEW YORK, NY) reported a portfolio value of $12.07B across 135 positions in their Q4 2015 SEC 13F filing (period ending 2015-12-31). The top 10 positions account for 75.8% of the portfolio.
Top 30 holdings by portfolio weight. Block width = holding percentage. Green = new/increased, red = reduced, gray = unchanged.
| # | Stock | Value↓ | Weight | Change |
|---|---|---|---|---|
| 1 | INCYIncyte Corporation | $2.11B | 17.50% | +0.0% |
| 2 | SGENEURSeattle Genetics, Inc. | $1.67B | 13.87% | +3.5% |
| 3 | ALXNAlexion Pharmaceuticals, Inc. | $1.25B | 10.34% | - |
| 4 | ABBVAbbVie Inc. | $851.49M | 7.05% | - |
| 5 | ACADACADIA Pharmaceuticals Inc. | $730.16M | 6.05% | - |
| 6 | Incyte Corporation | $596.53M | 4.94% | - |
| 7 | Incyte Corporation | $556.69M | 4.61% | - |
| 8 | GHDXGenomic Health, Inc. | $480.81M | 3.98% | +0.0% |
| 9 | Anacor Pharmaceuticals, Inc. | $474.31M | 3.93% | +1.5% |
| 10 | BMRNBioMarin Pharmaceutical Inc. | $431.10M | 3.57% | +1.0% |
| Stock | Value | Shares |
|---|---|---|
| ANAC 2 10/15/21Anacor Pharmaceuticals Inc. | $152.29M | 42,000,000 |
| ALKSAlkermes PLC | $19.86M | 250,251 |
| AAAPGBPAdvanced Accelerator Applications SA | $17.74M | 567,454 |
| Dimension Therapeutics, Inc. | $13.93M | 1,234,481 |
| Medgenics Inc. | $4.61M | 765,000 |
| AMRN 3.5 01/15/32 2014Corsicanto Ltd. | $4.48M | 5,000,000 |
| IONSIonis Pharmaceuticals, Inc. | $3.54M | 57,140 |
| Flexion Therapeutics, Inc. | $2.83M | 146,642 |
Get alerts when BAKER BROS. ADVISORS LP files new 13F holdings.